Chase AIPricingFAQs
Display currency
Loading news…

WittGen Biotechnologies

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Medium growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Berkeley, California, United States Founded 2023 1-10 employees For Profit

WittGen Biotechnologies utilizes a single-cell RNA sequencing data analysis and testing to overcome the heterogeneity of cancer.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
1

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
14
IT spend
$247K

Company Info

Founded
2023
Employees
1-10
Operating status
Active
Company type
For Profit
Org types
company
Founders
3
News articles
3
HQ
Berkeley, California, United States
Region
San Francisco Bay Area, West Coast, Western US

Signals & Scores

Heat score
High
Growth score
Medium
Trend (7d)
0
Trend (30d)
-1.1
Trend (90d)
3.1

Key People at WittGen Biotechnologies

Co-Founder & CSO
Co-Founder & CTO
CEO & Founder
1
professional contacts at WittGen Biotechnologies
Contact execs at WittGen Biotechnologies

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to WittGen Biotechnologies

Loading news…

FAQs about WittGen Biotechnologies

People who checked this page also checked these

Browse the full Acquirezy directory.
WittGen Biotechnologies - Company Profile, Full Acquisitions List, Funding and Investments